`_______________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`_____________
`
`
`
`PHARMACOSMOS A/S,
`Petitioner,
`
`v.
`
`LUITPOLD PHARMACEUTICALS, INC.,
`Patent Owner.
`
`
`
`_______________
`
`IPR2015-01490; Patent 7,754,702 B2
`____________________________________________________________
`
`CORRECTED PATENT OWNER EXHIBIT LIST AS OF APRIL 25, 2016
`
`
`
`
`
`4820-4731-8832.1
`
`
`
`IPR2015-01490
`
`
`
`Patent Owner Exhibit List
`
`CORRECTED PATENT OWNER EXHIBIT LIST AS OF APRIL 25, 2016
`
`Exhibit No.
`
`Description
`
`2001
`
`2002
`
`2003
`
`2004
`
`2005
`
`2006
`
`2007
`
`2008
`
`2009
`
`2010
`
`2011
`
`2012
`
`2013
`
`2014
`
`2015
`
`2016
`
`2017
`
`2018
`
`2019
`
`2020
`
`Imferon US Drug Monograph, Revised May 1989
`
`INFeD US Drug Monograph, Revised September 1996
`
`Ferrosig Drug Product Data Sheet, Revised July 2003
`
`European Search Report, October 21, 2009 in EP 07716309
`
`Prosecution History of the ’549 patent
`
`Prosecution History of the ’612 Patent
`
`Prosecution History of U.S. Application No. 13/847,254
`
`Parham, The Immune System. Garland Science 2000 p. 1-30.
`Folb, The Safety of Iron Dextran and a Comparison with Iron
`Sucrose for Intravenous Use, Submitted to the WHO October 2004
`
`Zager et al., Kidney Int. 2004 66(1):144-56
`
`Agarwal et al., Kidney Int. 2004 65(6):2279-89
`
`Fishbane, Am. J. Kidney Dis. 41(5 Suppl):18-26 (2003) (“Fishbane”)
`
`Cisar et al. J. Exp. Med. 142(1):435-459 (1975) (“Cisar”)
`
`Wallerstein, Blood. 1968 32(4):690-5
`
`Volhardt, Organic Chemistry, W.H. Freeman Co 2007 p. 1096-138
`
`USPTO PaFT Help Page
`
`Luitpold Pharmaceuticals, Inc. Executive Biographies
`
`Did Not Use
`
`Did Not Use
`
`Did Not Use
`
`4820-4731-8832.1
`
`
`
`IPR2015-01490
`
`
`
`Patent Owner Exhibit List
`
`Did Not Use
`
`Ahsan et al., Adv. Perit. Dial. 1996 12:161-6
`
`Dextran and Related Polysaccharides from Sigma-Aldrich
`
`Nomenclature of Carbohydrates, 1996
`
`Annual Meeting of the ACS Committee on Nomenclature,
`Terminology And Symbols
`
`Tandem MS can Distinguish Haluronic Acid from N-
`Acetylheparosan
`
`Production and Chemical Processing of Low Molecular Weight
`Heparins
`
`Did Not Use
`
`Did Not Use
`
`Did Not Use
`
`Did Not Use
`
`Did Not Use
`
`Did Not Use
`
`Did Not Use
`
`Did Not Use
`
`Fielding et al. British Medical Journal 279-283 (1961) (“Fielding”)
`
`Kabat et al. J. Immunol. 70:514-531(1953) (“Kabat”)
`
`WO 1997/011711 (“Lawrence PCT”)
`
`U.S. Patent No. 6,960,571 to Helenek (“the ’571 patent”)
`
`Landry et al. Am. J. Nephrol. 25(4):400-410 (2005) (“Landry”)
`
`2021
`
`2022
`
`2023
`
`2024
`
`2025
`
`2026
`
`2027
`
`2028
`
`2029
`
`2030
`
`2031
`
`2032
`
`2033
`
`2034
`
`2035
`
`2036
`
`2037
`
`2038
`
`2039
`
`2040
`
`4820-4731-8832.1
`
`
`
`IPR2015-01490
`
`
`
`Patent Owner Exhibit List
`
`2041
`
`2042
`
`2043
`
`2044
`
`2045
`
`2046
`
`2047
`
`2048
`
`2049
`
`2050
`
`2051
`
`2052
`
`2053
`
`2054
`
`2055
`
`2056
`
`2057
`
`2058
`
`Beshara et al. Br J Haematol. 120(5):853-9 (2003). (“Beshara”)
`
`Haines et al. Internal Med. Journal 39: 252-255 (2009) (“Haines”)
`
`Newnham et al. Internal Med. Journal 36(10): 672-674 (2006)
`(“Newnham”)
`
`Andersson Br Med J. 2(5247):275-279 (1961). (“Andersson”)
`
`Bailie et al. Neprol. Dial. Transplant 20:1443-1449 (2005) (“Bailie”)
`
`NKF-KDOQI (2000) (“Eschbach”)
`
`MacDougall Neprol. Dial. Transpland 15(Ed. Comments):1743-1745
`(2000) (“MacDougall”)
`
`Kudasheva et al. J. Inorganic Biochem. 98:1757-1769 (2004)
`(“Kudasheva”)
`
`Van Wyck et al. J. Am Soc Nephrol 15: S91-92, S107-S111
`(2004)(“Van Wyck”)
`
`U.S. Publication No. 2008/0234226
`
`Sipe et al. Brain Iron Metabolism and Neurodegenerative Disorders
`24(2-3):188-196 (2002) (“Sipe”)
`
`Sofic et al. J. Neural Transm. 74: 199-205 (1988) (“Sofic”)
`
`Did Not Use
`
`U.S. Patent No. 5,624, 668 (“Lawrence”)
`(Exhibit 1010 –IPR2015-01493)
`
`Hamstra et al. JAMA 243:1726-1731(1980) (“Hamstra”)
`(Exhibit 1008 –IPR2015-01493)
`
`Transcript of March 2016 Deposition of Dr. Robert Linhardt.
`
`Curriculum Vitae of Dr. Adriana Manzi.
`
`Did Not Use
`
`4820-4731-8832.1
`
`
`
`IPR2015-01490
`
`
`
`Patent Owner Exhibit List
`
`2059
`
`2060
`
`2061
`
`2062
`
`2063
`
`2064
`
`2065
`
`2066
`
`2067
`
`2068
`
`2069
`
`2070
`
`2071
`
`2072
`
`2073
`
`2074
`
`2075
`
`2076
`
`2077
`
`2078
`
`2079
`
`2080
`
`4820-4731-8832.1
`
`Did Not Use
`
`Did Not Use
`
`Did Not Use
`
`Did Not Use
`
`Did Not Use
`
`Did Not Use
`
`Did Not Use
`
`Did Not Use
`
`Did Not Use
`
`Did Not Use
`
`Did Not Use
`
`Did Not Use
`
`Did Not Use
`
`Did Not Use
`
`Did Not Use
`
`Did Not Use
`
`Did Not Use
`
`Did Not Use
`
`Did Not Use
`
`Did Not Use
`
`Did Not Use
`
`Declaration of Dr. Adriana Manzi
`
`
`
`IPR2015-01490
`
`
`
`Patent Owner Exhibit List
`
`2081
`
`2082
`
`2083
`2084
`
`2085
`
`2086
`
`2087
`
`Walters et al. Nephrol. Dial. Transplant 20:1438–1442 (2005)
`(“Walters”)
`
`Lindvall et al. Brit. J. Pharmacol. 17:358-371 (1961). (“Lindvall”)
`
`U.S. Provisional Application 60/757,119 (“the ’119 Application”)
`Lam-Po-Tang, et al. Peritoneal Dialysis International Jul-Aug
`23:405-406 (2003)
`
`Sax, N. I. and Lewis, R. J., Hawley’s Condensed Chemical
`Dictionary, Van Nostrand Reinhold Company, Eleventh Ed. (1987),
`p. 797, 1081-1082
`
`Morris, et al. Journal of Supramolecular Structure 6:259-274 (1977)
`
`KDOQI Clinical Practice Guidelines and Clinical Practice
`Recommendations for Anemia in Chronic Kidney Disease (2006)
`
`4820-4731-8832.1
`
`
`
`IPR2015-01490
`
`Patent Owner Exhibit List, Certificate of Service
`
`CERTIFICATE OF SERVICE
`
`The undersigned certifies that a copy of the Corrected Patent Owner Exhibit
`
`List as of April 25, 2016 as well as copies of Corrected Exhibits 2039 and 2080
`
`are being served on April 25, 2016, by filing them through the Patent Review
`
`Processing System as well as delivering copies via email to the following counsel
`
`for the Petitioner:
`
`Lisa Kole
`Baker Botts L.L.P.,
`30 Rockefeller Plaza, 45th Floor,
`New York, NY 10112
`E-mail: lisa.kole@bakerbotts.com
`
`Steven Lendaris
`Baker Botts L.L.P.,
`E-mail: steven.lendaris@bakerbotts.com
`
`Paul Ragusa
`Baker Botts L.L.P.,
`E-mail: paul.ragusa@bakerbotts.com
`
`
`
`4820-4731-8832.1
`
`
`/George E. Quillin/
`George E. Quillin
`Registration No. 32,792
`Counsel for Patent Owner